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KaplaneMeier curves and the Log-rank test.
Results: There is increased tumour epithelial cytoplasmic staining for
NR4A2, and an altered nuclear-cytoplasmic ratio with more cytoplasmic
NR4A2 in tumour compared to matched normal tissue (p ¼ 0.001). High
tumour cytoplasmic NR4A2 is associated with a signiﬁcantly worse overall
and disease speciﬁc survival in colorectal cancer. (5-year DSS 64% high
cytoplasmic NR4A2 versus 80% low cytoplasmic NR4A2, log-rank test
p¼0.049, 5-year OS p¼0.003)
Conclusions: There is marked cytoplasmic mislocalisation of NR4A2 in
colon cancer. High tumour cytoplasmic NR4A2 is associated with an
adverse prognosis.
0921: LOCALISED INHIBITION OF MICRORNA-15 AND -16 RESULTS IN AN
IMPROVED ANGIOGENIC RECOVERY FOLLOWING LIMB ISCHAEMIA
Saran Shantikumar*, Lynsey Howard, Micol Marchetti, Marco Meloni,
Costanza Emanueli. Bristol Heart Institute, Bristol, UK.
Introduction: MicroRNAs (miRNA;miR) are small non-coding RNAswhich
negatively regulatemRNA translation. miR-15&miR-16 are upregulated in
response to myocardial ischaemia, whilst inhibition protects against car-
diac ischaemic injury in a mouse model. We investigated the effect of
adenovirus-mediated local miR-15/16 inhibition in a mouse model of
hindlimb ischaemia.
Method: We generated an adenovirus capable of overexpressing a miRNA
inhibitor (Ad.Decoy-15/16), containing multiple, tandem complementary
binding sites for miR-15 and miR-16, and thus allowing speciﬁc and efﬁ-
cient depression of miR-15/16 expression. Unilateral hindlimb ischaemia
was surgically induced in anaesthetised CD1 mice (n¼12 per group) and
Ad.Decoy-15/16 or an Ad.Null control (10^9 virus particles) were delivered
to the ipsilateral adductor muscle.
Results: Blood ﬂow to the ischaemic limb was signiﬁcantly improved by
Ad.Decoy-15/16 at 7 (p<0.04), 14 (p<0.01) and 21 (p<0.03) days post-
surgery, with an average increase of ~50% compared to control mice.
Subsequent histopathological analyses at day 21 demonstrated an increase
in both capillary density (by ~30%, p<0.041) and arteriolar density (by
~40%, p<0.03) in the ischaemic adductor muscles of Ad.Decoy-15/16-
treated mice compared with control.
Conclusions: These data indicate a pro-angiogenic effect of localised
miR-15/16 inhibition in the setting of peripheral limb ischaemia in
mice.
0942: THE ROLE OF MICRORNA-30C-2* AS AN ANTIANGIOGENIC MEDI-
ATOR
Saran Shantikumar*, Andrea Caporali, Micol Marchetti, Marco Meloni,
Lynsey Howard, Costanza Emanueli. Bristol Heart Institute, Bristol, UK.
Introduction: MicroRNAs (miRs) negatively regulate the expression of
targeted mRNAs. Here, we aim to elucidate the contribution of miR-30c2*
in endothelial cell (EC) dysfunction in diabetes.
Methods: miR30c2* functional studies were performed in human
umbilical vein endothelial cells (HUVECs) under conditions of high
glucose (HG, mimics diabetes) and low growth factors (LGF, mimics
ischaemia). Expressional analyses were performed in mice, with and
without diabetes, using whole limb muscle and the ECs derived from
these tissues.
Results: MicroRNA-30c-2* expression was upregulated under LGF, HG and
a LGF/HG combination (p<0.01). In addition, miR-30c-2* was three-fold
upregulated in muscular ECs of diabetic mice (p<0.01). miR-30c-2* over-
expression induced HUVEC apoptosis and impaired angiogenesis.
Conversely, miR-30c-2* inhibition prevented LGF- and LGF/HG-induced
apoptosis and impaired angiogenesis.
The cell cycle regulator minichromosome maintenance complex compo-
nent 7 (MCM7) is a putative miR-30c-2* target. MCM-7 mRNA levels were
decreased in p75NTR-HUVECs (p<0.05 vs. Null) and in HUVECs cultured in
HG/LGF (p<0.05). miR-30c-2* overexpression reduced MCM7 mRNA
(p<0.01).
Conclusions: In conclusion, the p75NTR-induced miRNA miR-30c-2* re-
presses EC survival and angiogenesis, and may prove to be a novel thera-
peutic target for diabetes-induced endothelial damage in limbs.0967: CHARACTERIZATION OF INITIATING PHYSIOLOGICAL EVENTS OF
MAMMARY GLAND INVOLUTION: EVIDENCE FOR CATHEPSIN B
INVOLVEMENT
Vlad Paraoan 1,*, Christine Watson 2. 1 Trinity College, Cambridge University,
Cambridgeshire, UK; 2Department of Pathology, Cambridge University,
Cambridgeshire, UK.
Introduction: The mechanism of one of the most extensive physiological
cell death in mammals, postlactational regression (involution) of the
mammary gland, was recently characterized as a non-classical, lysosomal-
mediated and caspase-independent pathway of cell death. Expression of
cysteine proteinases cathepsins B and L was shown to be highly increased
via Stat3 pathway during this process. The present study aimed to inves-
tigate the intracellular trafﬁcking and potential involvement of cathepsins
B and L in the physiological events leading to involution mediated by
lysosomal membrane permeability.
Methods: Fluorescent immunohistochemical staining of mammary gland
sections fromwild type and Stat3 KOmice was performed for cathepsins B,
L and aelactalbumin, alongside co-staining of the lysosome associated
membrane protein-2 (LAMP2). Intracellular (co-) localizationwas analysed
by deconvolution ﬂuorescence microscopy.
Results: Both cathepsins B and L, but not aelactalbumin, showed strong
co-localization with LAMP2, indicating lysosomal translocation, in the
presence of functional wild-type Stat3. The co-localization with the lyso-
somal membrane was signiﬁcantly reduced, most severely in the case of
cathepsin B, in Stat3 KO mice compared with wild-type.
Conclusions: The strong Stat3-dependent lysosomal membrane localiza-
tion of cathepsin B suggests a role for this proteinase in triggering the
lysosomal membrane permeability associated with the mammary gland
involution.
0988: M1 POLARISED MACROPHAGES DEVELOP AN ENDOTOXIN TOLER-
ANCE-LIKE PHENOMENON IN RESPONSE TO BACTERIAL STIMULATION
N.M. Foley*, J.H. Wang, H.P. Redmond. Cork University Hospital/University
College Cork, Cork, Ireland.
Introduction: To establish a predominant M1and M2 macrophage polar-
isation pattern in vitro. To examine the inﬂammatory cytokine response to
bacterial stimulation in polarised cells. To determine the phagocytic ac-
tivity in polarised cells after bacterial stimulation.
Methods: Peritoneal and bone marrow derived macrophages were har-
vested from C57BL/6 mice. Cells were exposed to polarising stimuli for 18-
24 hours. (M1 - LPS and IFN-g, M2 - IL-4). Polarised cells were further
stimulated with heat-killed Staphylococcus aureus and Salmonella Typhi
or FITC-labeled E coli. Inﬂammatory cytokine production and phagocytosis
were assessed by ELISA and FACScan analysis.
Results: M1 macrophages were characterised by high levels of TNF-a and
IL-12p70 and M2 macrophages by high levels of TGF-b and low levels of
IL12p70. M1 polarized macrophages, when exposed to gram-positive
bacteria, had lower levels of TNF-a than M2 macrophages. Phagocytosis
assays revealed similar results for both macrophage subpopulations.
Conclusions:M1macrophages are expected to produce higher levels of TNF-
a, however we found that M1macrophages, when stimulated with bacteria,
had lower levels of TNF-a compared with their M2 counterparts. This unex-
pected result indicates a tolerisation effect developed during the M1 polar-
isation and further work is required to clarify the underlying mechanism(s).
1094: ASSOCIATION BETWEEN LEVELS OF MATRIX METALLOPROTEI-
NASE-3 AND JOINT REPLACEMENT OF THE HIP AND KNEE IN RHEUMA-
TOID ARTHRITIS
Cara Jenvey 1,*, Samantha Hider 2, John Glossop 1, Jonathan Packham 1,
Peter Dawes 1, Nicola Nixon 1, Derek Mattey 1. 1Haywood Rheumatology
Centre, Haywood Hospital, Stoke-on-Trent, UK; 2Research Institute for
Primary Care and Health Sciences, Keele University, Stoke-on-Trent, UK.
Introduction: Within 20 years 25% of rheumatoid arthritis (RA) patients
will undergo total joint replacement. Matrix metalloproteinase-3 (MMP-3)
is released during the disease process. Previous studies suggest that MMP-
3 levels decrease following joint replacement. The objective of this study
was to investigate if serum levels of MMP-3 at baseline are associated with
future joint replacement of the hip and knee.
